BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1174 related articles for article (PubMed ID: 23852170)

  • 21. Genetic inhibitors of APOBEC3B-induced mutagenesis.
    Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Cordero C; Bray N; Harcy V; Vyas RK; Mitchell D; Lobachev K; Roberts SA
    Genome Res; 2023 Sep; 33(9):1568-1581. PubMed ID: 37532520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOBEC: From mutator to editor.
    Yang B; Li X; Lei L; Chen J
    J Genet Genomics; 2017 Sep; 44(9):423-437. PubMed ID: 28964683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOBEC mutagenesis is a common process in normal human small intestine.
    Wang Y; Robinson PS; Coorens THH; Moore L; Lee-Six H; Noorani A; Sanders MA; Jung H; Katainen R; Heuschkel R; Brunton-Sim R; Weston R; Read D; Nobbs B; Fitzgerald RC; Saeb-Parsy K; Martincorena I; Campbell PJ; Rushbrook S; Zilbauer M; Buczacki SJA; Stratton MR
    Nat Genet; 2023 Feb; 55(2):246-254. PubMed ID: 36702998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
    Shi R; Wang X; Wu Y; Xu B; Zhao T; Trapp C; Wang X; Unger K; Zhou C; Lu S; Buchner A; Schulz GB; Cao F; Belka C; Su C; Li M; Shu Y
    Theranostics; 2022; 12(9):4181-4199. PubMed ID: 35673559
    [No Abstract]   [Full Text] [Related]  

  • 25. Correlation of gene expression and associated mutation profiles of APOBEC3A, APOBEC3B, REV1, UNG, and FHIT with chemosensitivity of cancer cell lines to drug treatment.
    Vural S; Simon R; Krushkal J
    Hum Genomics; 2018 Apr; 12(1):20. PubMed ID: 29642934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.
    Petljak M; Alexandrov LB; Brammeld JS; Price S; Wedge DC; Grossmann S; Dawson KJ; Ju YS; Iorio F; Tubio JMC; Koh CC; Georgakopoulos-Soares I; Rodríguez-Martín B; Otlu B; O'Meara S; Butler AP; Menzies A; Bhosle SG; Raine K; Jones DR; Teague JW; Beal K; Latimer C; O'Neill L; Zamora J; Anderson E; Patel N; Maddison M; Ng BL; Graham J; Garnett MJ; McDermott U; Nik-Zainal S; Campbell PJ; Stratton MR
    Cell; 2019 Mar; 176(6):1282-1294.e20. PubMed ID: 30849372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
    Henderson S; Chakravarthy A; Su X; Boshoff C; Fenton TR
    Cell Rep; 2014 Jun; 7(6):1833-41. PubMed ID: 24910434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOBEC-mediated editing of viral RNA.
    Bishop KN; Holmes RK; Sheehy AM; Malim MH
    Science; 2004 Jul; 305(5684):645. PubMed ID: 15286366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOBEC mediated mutagenesis drives genomic heterogeneity in endometriosis.
    Revathidevi S; Nakaoka H; Suda K; Fujito N; Munirajan AK; Yoshihara K; Enomoto T; Inoue I
    J Hum Genet; 2022 Jun; 67(6):323-329. PubMed ID: 35017684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell-Mediated Antitumor Immune Responses.
    DiMarco AV; Qin X; McKinney BJ; Garcia NMG; Van Alsten SC; Mendes EA; Force J; Hanks BA; Troester MA; Owzar K; Xie J; Alvarez JV
    Cancer Immunol Res; 2022 Jan; 10(1):70-86. PubMed ID: 34795033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
    Oka K; Kobayashi K; Sullivan M; Martinez J; Teng BB; Ishimura-Oka K; Chan L
    J Biol Chem; 1997 Jan; 272(3):1456-60. PubMed ID: 8999814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma.
    Cannataro VL; Gaffney SG; Sasaki T; Issaeva N; Grewal NKS; Grandis JR; Yarbrough WG; Burtness B; Anderson KS; Townsend JP
    Oncogene; 2019 May; 38(18):3475-3487. PubMed ID: 30647454
    [TBL] [Abstract][Full Text] [Related]  

  • 33. APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database.
    Lindley RA; Hall NE
    Mutat Res; 2018 Jul; 810():33-38. PubMed ID: 29957488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNAs regulate APOBEC gene expression.
    Cao W; Wu W
    Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolutionary origins of the mammalian apolipoproteinB RNA editing enzyme, apobec-1: structural homology inferred from analysis of a cloned chicken small intestinal cytidine deaminase.
    Anant S; Yu H; Davidson NO
    Biol Chem; 1998; 379(8-9):1075-81. PubMed ID: 9792440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
    Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
    Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.
    Faden DL; Ding F; Lin Y; Zhai S; Kuo F; Chan TA; Morris LG; Ferris RL
    Oral Oncol; 2019 Sep; 96():140-147. PubMed ID: 31422205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypermutation induced by APOBEC-1 overexpression can be eliminated.
    Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Csako G; Patterson AP
    RNA; 2010 May; 16(5):1040-52. PubMed ID: 20348446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.
    Yamanaka S; Poksay KS; Driscoll DM; Innerarity TL
    J Biol Chem; 1996 May; 271(19):11506-10. PubMed ID: 8626710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modelling of the biosynthesis of the RNA-editing enzyme APOBEC-1, responsible for generating the alternative forms of apolipoprotein B.
    Scott J; Navaratnam N; Carter C
    Exp Physiol; 1999 Jul; 84(4):791-800. PubMed ID: 10481235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.